Hot Pursuit     08-Jun-20
Marksans Pharma Ltd Slips 4.87%
Marksans Pharma Ltd has added 61.76% over last one month compared to 5.09% gain in S&P BSE Healthcare index and 10.12% rise in the SENSEX

Marksans Pharma Ltd fell 4.87% today to trade at Rs 30.25. The S&P BSE Healthcare index is down 0.68% to quote at 16048.9. The index is up 5.09 % over last one month. Among the other constituents of the index, Divis Laboratories Ltd decreased 3.89% and Medicamen Biotech Ltd lost 2.47% on the day. The S&P BSE Healthcare index went up 23.08 % over last one year compared to the 12.04% fall in benchmark SENSEX.

Marksans Pharma Ltd has added 61.76% over last one month compared to 5.09% gain in S&P BSE Healthcare index and 10.12% rise in the SENSEX. On the BSE, 8.2 lakh shares were traded in the counter so far compared with average daily volumes of 1.73 lakh shares in the past one month. The stock hit a record high of Rs 33.35 on 08 Jun 2020. The stock hit a 52-week low of Rs 9.9 on 24 Mar 2020.

Previous News
  Marksans Pharma rises after subsidiary gets EIR for New York-based facility from US FDA
 ( Hot Pursuit - 30-Jun-25   12:58 )
  Time-Cap Laboratories successfully concludes USFDA inspection
 ( Corporate News - 30-Jun-25   12:56 )
  Marksans Pharma’s UK arm gets marketing nod for Oxybutynin Oral solution from UKMHRA
 ( Hot Pursuit - 19-Jun-25   10:04 )
  Divis Laboratories Ltd up for third consecutive session
 ( Hot Pursuit - 11-Jun-25   13:05 )
  Medicamen Biotech rallies after securing USFDA approval for Bortezomib injection
 ( Hot Pursuit - 03-Jun-25   13:07 )
  Divis Laboratories Ltd down for fifth straight session
 ( Hot Pursuit - 02-Jun-25   13:35 )
  Board of Medicamen Biotech recommends final dividend
 ( Corporate News - 31-May-25   12:29 )
  Medicamen Biotech consolidated net profit rises 13.62% in the March 2025 quarter
 ( Results - Announcements 31-May-25   12:19 )
  Marksans Pharma gets regulatory nod for marketing type-2 diabetes medication in UK
 ( Hot Pursuit - 30-May-25   09:33 )
  Relonchem receives marketing authorization for Metformin Hydrochloride 500mg/ 5 ml Oral Solution in UK
 ( Corporate News - 30-May-25   09:13 )
  Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.
 ( Corporate News - 24-May-25   11:34 )
Other Stories
  ZEN Technologies ends higher after receiving patent for long-pass optical filter
  30-Jun-25   18:44
  Torrent Pharma gains after inking pact to acquire majority stake in JB Chemicals & Pharma
  30-Jun-25   16:02
  Suditi Industries jumps 17% in seven days
  30-Jun-25   15:23
  J B Chemicals & Pharmaceuticals Ltd leads losers in 'A' group
  30-Jun-25   15:00
  Aimtron Electronics gains on inking Rs 98-crore ODM contract with US Firm
  30-Jun-25   14:52
  Sigachi Industries Ltd leads losers in 'B' group
  30-Jun-25   14:45
  Sigachi Industries drops after deadly explosion at Telangana facility
  30-Jun-25   14:32
  Volumes soar at Alembic Pharmaceuticals Ltd counter
  30-Jun-25   14:30
  HEC Infra secures Rs 3-cr work order from Ahmedabad Municipal Corporation
  30-Jun-25   14:26
  Jindal Steel commissions first galvanizing line at Angul Complex
  30-Jun-25   13:40
Back Top